Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ganetespib
Description:
An experimental small-molecule inhibitor of heat shock protein 90 studied as an anticancer agent.
Primary topic:
Heat shock proteins research (38%)
Related topics:
Heat shock proteins research (38%),
Lung Cancer Treatments and Mutations (14%)
Wikidata ID:
wiki/Q27254612
OpenAlex ID:
keywords/ganetespib
Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
2011
·
Weiwen Ying
, Zhenjian Du
, et al.
·
Molecular Cancer Therapeutics
·
240
A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer
2013
·
Mark A. Socinski
, Jonathan Goldman
, et al.
·
Clinical Cancer Research
·
227
Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2013
·
Jim Sang
, Jaime Acquaviva
, et al.
·
Cancer Discovery
·
225
Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
2012
·
Takeshi Shimamura
, Samanthi A. Perera
, et al.
·
Clinical Cancer Research
·
176
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
2017
·
Rina M. Mbofung
, Jodi A. McKenzie
, et al.
·
Nature Communications
·
162
PDF
Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain
2014
·
Mark W. Richards
, Edward W. P. Law
, et al.
·
Proceedings of the National Academy of Sciences
·
123
PDF
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
2013
·
Lisha Xiang
, Daniele M. Gilkes
, et al.
·
Journal of Molecular Medicine
·
118
A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
2013
·
Jonathan W Goldman
, Robert N Raju
, et al.
·
BMC Cancer
·
117
PDF
Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical Promise
2014
·
David A. Proia
, Richard C. Bates
·
Cancer Research
·
116
A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
2014
·
Komal Jhaveri
, Sarat Chandarlapaty
, et al.
·
Clinical Breast Cancer
·
115
Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib
2014
·
Jaime Acquaviva
, Donald L. Smith
, et al.
·
Molecular Cancer Therapeutics
·
112
Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer
2014
·
Ganji Purnachandra Nagaraju
, Tua‐Elisabeth Long
, et al.
·
Molecular Carcinogenesis
·
109
Ganetespib: research and clinical development
2015
·
Shanu Modi
, Komal Jhaveri
·
OncoTargets and Therapy
·
107
PDF
Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
2012
·
Jaime Acquaviva
, Donald L. Smith
, et al.
·
Molecular Cancer Therapeutics
·
105
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
2013
·
Purnachandra Nagaraju Ganji
, Wungki Park
, et al.
·
Angiogenesis
·
90
Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non–Small-Cell Lung Cancer (GALAXY-2)
2019
·
Rathi N. Pillai
, Dean A. Fennell
, et al.
·
Journal of Clinical Oncology
·
82
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
2012
·
David A. Proia
, Jim Sang
, et al.
·
Investigational New Drugs
·
82
PDF
Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
2011
·
David A. Proia
, Kevin P. Foley
, et al.
·
PLoS ONE
·
80
PDF
Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer
2015
·
Christine Mall
, Gail D. Sckisel
, et al.
·
OncoImmunology
·
79
PDF
FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism
2014
·
Jaime Acquaviva
, Suqin He
, et al.
·
Molecular Cancer Research
·
79
PDF
A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors
2013
·
Dan Zhou
, Yuan Liu
, et al.
·
Toxicology and Applied Pharmacology
·
78
PDF
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
2014
·
Ganji Purnachandra Nagaraju
, Olatunji B. Alese
, et al.
·
Oncotarget
·
77
PDF
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
2014
·
Suqin He
, Donald L. Smith
, et al.
·
Investigational New Drugs
·
77
PDF
Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer
2016
·
Tim N. Beck
, Vlad A. Korben
, et al.
·
Cell Reports
·
74
PDF
Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice
2023
·
Mahmoud E. Youssef
, Simona Cavalu
, et al.
·
International Journal of Molecular Sciences
·
73
PDF
Show more works
View as search
Works count:
491
Citation count:
7,411
Year
Topic
Type